Ptc Therapeutics Inc. (PTCT)
Market Closed
3 Jun, 20:00
$
68. 68
+0.45
+0.6595%
$
5.86B Market Cap
- P/E Ratio
- Div Yield
1.09M Volume
-5.84 Eps
$ 68.23
Previous Close 
Want to track PTCT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
PTC Therapeutics (PTCT) Soars 9.7%: Is Further Upside Left in the Stock?
PTC Therapeutics (PTCT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Zacks | 1 year ago
PTC Therapeutics (PTCT) Up as EC Returns CHMP Opinion on DMD Drug
PTC Therapeutics (PTCT) gains 21% on May 20 after the EC decided against adopting the negative CHMP opinion of January 2024 on the annual renewal of the conditional approval of Translarna.
Zacks | 2 years ago
